Study on the Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects
Clinical trial NCT07345442 · COMPLETED
Trial details
- NCT number
- NCT07345442
- Sponsor
- Anhui Palo Alto Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-14
- Primary completion
- 2025-06-09
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.